https://www.gosh.nhs.uk/our-research/recent-impact-of-research-and-innovation/infinity-and-beyond/
To infinity and beyond!
23 Nov 2018, 11:32 a.m.
Last week, GOSH patients were joined by former NASA Astronaut Nicole Scott and Tim Peake (by Skype) for an exciting art project that is travelling the world!Former NASA Astronaut Nicole Stott, and artists Ian Cion and Maria Lanas from the charity Space for Art Foundation (USA), visited GOSH to bring three art projects to raise awareness of childhood cancer. The aim of the foundation is to provide well-being activities that help children heal and feel connected to space through art.
The group brought their Exploration Art Spacesuit, and Earthrise – Spaceship Earth projects to the hospital, where children in Lion Ward had the chance to take part in arts-based activities, such as painting a canvas that will be quilted into the Dreamer spacesuit and creating their own interpretation of Earthrise images.
This project was in partnership with the charity Unity Movement based in Russia and Alyona Kuzmenko (Founder and President of the charity) will arrange for the newly-designed Dreamer canvas to travel to space!
The visit was sponsored by Professor Faraneh Vargha-Khadem, from the Neuropsychology Department at GOSH, and Cognitive Neuroscience and Neuropsychiatry Department at UCL GOS Institute of Child Health, to help promote the wellbeing of children with cancer, and support research on children’s mental health through the arts.
A catalyst to unlock the next generation of research leaders
The NIHR GOSH Biomedical Research Centre (BRC) Fellowships are transforming early-career researchers into independent leaders - driving innovation, attracting millions in funding and shaping the future of paediatric science.
Gene therapy successfully treats deadly childhood liver disease in mice
Researchers at GOSH and UCL have used a new gene therapy to successfully treat a deadly childhood liver disease in mice.
World-first gene therapy to target devastating rare immune disorder
A first-of-its-kind gene therapy to treat people with CTLA-4 insufficiency is being advanced through a collaboration supported by LifeArc, and developed by scientists at UCL, with manufacturing support from NHS Blood and Transplant and GOSH.
Shaping better research from the start
At GOSH, patient and public involvement is helping researchers to ask the right question, right from the start.